Tekla Capital Management LLC Kura Oncology, Inc. Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$11.23 - $16.9 $3.18 Million - $4.79 Million	283,281 New	283,281 $3.52 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $3.34 Million - $5.35 Million	-273,463 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$29.0 - $41.62 $6.21 Million - $8.91 Million	214,124 Added 360.85%	273,463 $8.93 Million
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $967,225 - $1.82 Million	59,339 New	59,339 $1.82 Million

192

81.7M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $579M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.